2014
DOI: 10.1590/s1984-82502011000100002
|View full text |Cite
|
Sign up to set email alerts
|

Polymorphism: an evaluation of the potential risk to the quality of drug products from the Farmácia Popular Rede Própria

Abstract: Polymorphism in solids is a common phenomenon in drugs, which can lead to compromised quality due to changes in their physicochemical properties, particularly solubility, and, therefore, reduce bioavailability. Herein, a bibliographic survey was performed based on key issues and studies related to polymorphism in active pharmaceutical ingredient (APIs) present in medications from the Farmácia Popular Rede Própria. Polymorphism must be controlled to prevent possible ineffective therapy and/or improper dosage. F… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
20
0

Year Published

2015
2015
2022
2022

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 42 publications
(20 citation statements)
references
References 192 publications
(82 reference statements)
0
20
0
Order By: Relevance
“…Anhydrous forms of drugs, for example, have a higher thermodynamic activity compared to the corresponding hydrates, and, consequently, increased solubility and dissolution rate. Different polymorphic forms can arise from the conditions employed in the synthesis and purification of the drug, depending, for example, on the type of solvent used and the reaction temperature [24,27,28].…”
Section: Factors Affecting Drug Bioavailability: Related To the Drugmentioning
confidence: 99%
“…Anhydrous forms of drugs, for example, have a higher thermodynamic activity compared to the corresponding hydrates, and, consequently, increased solubility and dissolution rate. Different polymorphic forms can arise from the conditions employed in the synthesis and purification of the drug, depending, for example, on the type of solvent used and the reaction temperature [24,27,28].…”
Section: Factors Affecting Drug Bioavailability: Related To the Drugmentioning
confidence: 99%
“…Therefore, they can have impact on solubility and dissolution rate of the drug. The strategy involves drug-coformer combinations that have the potential of forming energetically and structurally robust interactions [3][4][5][6][7][8]. Pharmaceutical cocrystals often rely on hydrogen-bonded assemblies between an API and coformer with well-defined stoichiometries.…”
Section: Introductionmentioning
confidence: 99%
“…Polymorphism is a frequently encountered problem faced by industry during the production of commercial pharmaceutical formulations that can alter physicochemical properties of resulting end-products (3). Many reviews are available in the literature describing the types of polymorphs and their significance in pharmaceutical industry (4)(5)(6). Due to the importance of polymorphism, it is essential to pay great heed during drug product development and regulatory review.…”
Section: Introductionmentioning
confidence: 99%